Press release
mRNA Vaccines and Therapeutics Market is projected to reach USD 253.83 billion by 2034, growing at a CAGR of 16.7%
mRNA Vaccines and Therapeutics Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide mRNA vaccines and therapeutics market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by type, application, treatment type, end user, and region in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/mrna-vaccines-and-therapeutics-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
mRNA vaccines and therapies are medical interventions that utilize messenger RNA (mRNA) to direct the body's cells to create particular proteins that elicit an immune response or address health conditions. In vaccines like those for COVID-19, mRNA carries instructions for a protein present in the virus, stimulating the immune system to identify and combat the pathogen. Additionally, mRNA therapeutics are under investigation to address several conditions, such as cancer and genetic disorders, by guiding cells to generate therapeutic proteins or amend defective ones.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โ Research and development (R&D), partnerships, and collaborations between key companies and research institutes are driving the innovation and creation of new mRNA vaccines by combining resources, expertise, and technologies to tackle scientific and production challenges.
โ The rise in regulatory authorizations for mRNA-based products is fueling the growth of the global mRNA vaccines and therapeutics market.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
Because there are so many companies in the market, it is expected to be both competitive and fragmented. Here are the top companies in the market:
โข Ethris
โข Sanofi
โข Arcturus Therapeutics
โข Innovac Therapeutics
โข Kernal Biologics
โข Pantherna Therapeutics
โข pHion Therapeutics
โข Recode Therapeutics
โข Rejuvenation Technologies
โข RNAimmune
โข Strand Therapeutics
โข Walvax
๐ฆ๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐ง๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.
โข Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.
โข In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
By Type Outlook (Revenue, USD Billion, 2020-2034)
โข Self-Amplifying mRNA-Based Vaccines
โข Conventional Non-Amplifying mRNA-Based Vaccines
By Application Outlook (Revenue, USD Billion, 2020-2034)
โข Cancer
โข Infectious Diseases
โข Autoimmune Diseases
โข Others
By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)
โข Monoclonal Antibody
โข Gene Therapy
โข Cell Therapy
โข Other
By End User Outlook (Revenue, USD Billion, 2020-2034)
โข Research Laboratories and Organizations
โข Hospitals
โข Clinics
โข Others
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, in 2024, North America had the largest market share. The region's robust healthcare infrastructure, coupled with significant investments in research and development, has facilitated rapid advancements in mRNA technology.
Also, Asia Pacific is anticipated to register a substantial CAGR during the projection period due to the growing investment in biotechnology, expanding clinical trials, and increasing rates of infectious and chronic illnesses.
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Clinical Trial Biorepository & Archiving Solutions Market
https://www.polarismarketresearch.com/industry-analysis/clinical-trial-biorepository-and-archiving-solutions-market
Plasma Protease C1-inhibitor Market
https://www.polarismarketresearch.com/industry-analysis/plasma-protease-c1-inhibitor-market
Dental Equipment Market
https://www.polarismarketresearch.com/industry-analysis/dental-equipment-market
Equine Healthcare Market
https://www.polarismarketresearch.com/industry-analysis/equine-healthcare-market
Immunoassay Market
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Vaccines and Therapeutics Market is projected to reach USD 253.83 billion by 2034, growing at a CAGR of 16.7% here
News-ID: 3797875 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA โฆ
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, andโฆ
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca โฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,โฆ
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca โฆ
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
โข 70% efforts of Primary Research
โข 15% efforts of Secondary Research
โข 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limitedโฆ
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin โฆ
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
โข The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
โข Expected exponentialโฆ
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe โฆ
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers aโฆ
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te โฆ
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and mayโฆ
